文献速递肝病

系统综述与荟萃分析:非酒精性脂肪性肝病的危险因素提示瘦型与肥胖患者共享代谢和心血管特征改变

Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.
PubMed 文献 · Aliment Pharmacol Ther · 2017-05-02

该系统综述与荟萃分析纳入15项研究及作者自身336例患者数据,分析瘦型(n=1966)与肥胖(n=5938)非酒精性脂肪性肝病(NAFLD)患者,对照为瘦型(n=9946)与肥胖(n=6027)无NAFLD者。结果显示瘦型NAFLD患者较瘦型无NAFLD对照者年龄更大且呈现全套代谢综合征危险因素,肥胖组改变较瘦型更严重,无论有无NAFLD;荟萃回归提示NAFLD是血脂水平的修饰因素。作者结论为瘦型与肥胖NAFLD患者共享常见代谢和心血管特征改变。

要点

  • 瘦型NAFLD患者较瘦型无NAFLD对照者年龄更大,并呈现全套代谢综合征危险因素。
  • 瘦型NAFLD患者较瘦型无NAFLD对照者血糖、HOMA-IR、血脂、血压及腰围均显著升高。
  • 肥胖组总体改变较瘦型更严重,无论有无NAFLD;荟萃回归提示NAFLD是血脂水平的修饰因素。

核心结论

  • 瘦型与肥胖NAFLD患者共享常见代谢和心血管特征改变;瘦型患者体重正常但腹部脂肪过多并具有其他代谢综合征特征。

研究设计与样本

  • 系统综述与荟萃分析,纳入15项研究及作者自身人群数据(n=336例患者)。
  • 瘦型NAFLD患者n=1966,肥胖NAFLD患者n=5938;瘦型无NAFLD对照n=9946,肥胖无NAFLD对照n=6027。

主要发现

  • 较瘦型无NAFLD对照,瘦型NAFLD患者年龄更大(3.79±0.72年,P=1.36×10-6)。
  • 较瘦型无NAFLD对照,瘦型NAFLD患者血浆葡萄糖升高(6.44±1.12 mg/dL,P=10-10),HOMA-IR升高(0.52±0.094单位,P=10-10)。
  • 较瘦型无NAFLD对照,瘦型NAFLD患者甘油三酯升高(48.37±3.6 mg/dL,P=10-10),总胆固醇升高(7.04±3.8 mg/dL,P=4.2×10-7)。
  • 较瘦型无NAFLD对照,瘦型NAFLD患者收缩压升高(5.64±0.7 mm Hg,P=10-10),舒张压升高(3.37±0.9 mm Hg,P=10-10),腰围增加(5.88±0.4 cm,P=10-10);数值为均数差±标准误。
  • 肥胖组总体改变较瘦型更严重,无论有无NAFLD;荟萃回归提示NAFLD是血脂水平的修饰因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The pathogenesis of non-alcoholic fatty liver disease (NAFLD) is closely associated with the co-occurrence of multiple pathological conditions characterising the metabolic syndrome (MetS), obesity in particular. However, NAFLD also develops in lean subjects, whose risk factors remain poorly defined. METHODS: We performed a meta-analysis of 15 studies, along with the data pertaining to our own population (n=336 patients). Data from lean (n=1966) and obese (n=5938) patients with NAFLD were analysed; lean (n=9946) and obese (n=6027) subjects without NAFLD served as controls. RESULTS: Relative to the lean non-NAFLD controls, lean patients with NAFLD were older (3.79±0.72 years, P=1.36×10-6 ) and exhibited the entire spectrum of the MetS risk factors. Specifically, they had a significant (P=10-10 ) increase in plasma glucose levels (6.44±1.12 mg/dL) and HOMA-IR (0.52±0.094-unit increment), blood lipids (triglycerides: 48.37±3.6, P=10-10 and total cholesterol: 7.04±3.8, mg/dL, P=4.2×10-7 ), systolic (5.64±0.7) and diastolic (3.37±0.9) blood pressure (mm Hg), P=10-10 , and waist circumference (5.88±0.4 cm, P=10-10 ); values denote difference in means±SE. Nevertheless, the overall alterations in the obese group were much more severe when compared to lean subjects, regardless of the presence of NAFLD. Meta-regression suggested that NAFLD is a modifier of the level of blood lipids. CONCLUSION: Lean and obese patients with NAFLD share a common altered metabolic and cardiovascular profile. The former, while having normal body weight, showed excess of abdominal adipose tissue as well as other MetS features.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther. 2017. PMID: 28464369. doi:10.1111/apt.14112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。